~ Vitamin C May Have Beneficial Effects on Nitric Oxide Bioavailability Induced by L-Arginine
Researchers have investigated the effects of vitamin C on intracoronary L-arginine-dependent coronary vasodilatation in patients with stable angina.
Scientists in Greece conducted a study "to assess the effects of intravenous vitamin C administration on the vasomotor responses to intracoronary L-arginine infusion in epicardial coronary arteries."
D. Tousoulis and colleagues of the University of Athens explained, "28 patients with coronary artery disease and stable angina were enrolled in the study. Eight patients received intracoronary infusions of 150 mmol/min L-arginine before and after intravenous infusion of vitamin C, 10 patients received intracoronary infusions of 150 mcmol/min L-arginine before and after intravenous infusion of normal saline, and 10 patients received intracoronary normal saline before and after intravenous infusion of vitamin C. The diameter of proximal and distal coronary artery segments was measured by quantitative angiography."
"Infusion of L-arginine caused significant dilatation of both proximal (4.87 (0.96)%, p<0.01 vs. normal saline) and distal (6.33 (1.38)%, p<0.01 vs. normal saline) coronary segments," the researchers reported. "Co-infusion of vitamin C and L-arginine dilated proximal coronary segments by 8.68 (1.40)% (p<0.01 vs. normal saline, p<0.01 vs. L-arginine) and distal segments by 13.07 (2.15)% (p<0.01 vs. normal saline, p<0.01 vs. L-arginine)."
"Intravenous infusion of vitamin C caused a borderline increase in proximal and distal coronary segment diameters(1.93 (0.76)% and 2.09 (1.28)%, respectively, not significant)," the authors noted.
They concluded, "L-arginine dependent coronary segment vasodilatation was augmented by the antioxidant vitamin C in patients with coronary artery disease. Thus, vitamin C may have beneficial effects on nitric oxide bioavailability induced by L-arginine."
Tousoulis and colleagues published their study in Heart (Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina. Heart, 2005;91(10):1319-1323).
For additional information, contact D. Tousoulis, University of Athens School of Medicine, S Karagiorga 69, Athens 16675, Greece. email@example.com
The publisher's contact information for the journal Heart is: BMJ Publishing Group, British Medical Association House, Tavistock Square, London WC1H 9JR, England.
This article was prepared by Biotech Week editors from staff and other reports. Copyright 2005, Biotech Week via NewsRx.com.
To see more of the NewsRx.com, or to subscribe, go to http://www.newsrx.com.
FREE SHIPPING IN THE CONTINENTAL UNITED STATES!
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.
While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Extension Institute assumes no liability for inaccuracies or misstatements about products.